These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 1313656)

  • 1. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.
    Herwaldt BL; Berman JD
    Am J Trop Med Hyg; 1992 Mar; 46(3):296-306. PubMed ID: 1313656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium stibogluconate (Pentostam) overdose during treatment of American cutaneous leishmaniasis.
    Herwaldt BL; Kaye ET; Lepore TJ; Berman JD; Baden HP
    J Infect Dis; 1992 May; 165(5):968-71. PubMed ID: 1314873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis.
    Marsden PD; Sampaio RN; Carvalho EM; Veiga JP; Costa JL; Llanos-Cuentas EA
    Am J Trop Med Hyg; 1985 Jul; 34(4):710-3. PubMed ID: 2992304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
    Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
    Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of visceral leishmaniasis in children].
    Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
    Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.
    Navin TR; Arana BA; Arana FE; Berman JD; Chajón JF
    J Infect Dis; 1992 Mar; 165(3):528-34. PubMed ID: 1311351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine.
    Bryceson AD; Chulay JD; Mugambi M; Were JB; Gachihi G; Chunge CN; Muigai R; Bhatt SM; Ho M; Spencer HC
    Trans R Soc Trop Med Hyg; 1985; 79(5):705-14. PubMed ID: 3006295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
    Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
    Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis.
    Roberts WL; Hariprashad J; Rainey PM; Murray HW
    Am J Trop Med Hyg; 1996 Oct; 55(4):444-6. PubMed ID: 8916804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose sodium stibogluconate treatment of cutaneous leishmaniasis in Kenya.
    Chulay JD; Anzeze EM; Koech DK; Bryceson AD
    Trans R Soc Trop Med Hyg; 1983; 77(5):717-21. PubMed ID: 6318408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of pentostam against Panamanian mucosal leishmaniasis.
    Saenz RE; de Rodriguez CG; Johnson CM; Berman JD
    Am J Trop Med Hyg; 1991 Apr; 44(4):394-8. PubMed ID: 1645930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate).
    Chulay JD; Spencer HC; Mugambi M
    Am J Trop Med Hyg; 1985 Jul; 34(4):702-9. PubMed ID: 2992303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short term treatment of visceral leishmaniasis of the Old World with low dose interferon gamma and pentavalent antimony.
    van Lunzen J; Kern P; Schmitz J; Brzoska J; Flessenkämper S; Dietrich M
    Infection; 1993; 21(6):362-6. PubMed ID: 8132364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis.
    Franke ED; Llanos-Cuentas A; Echevarria J; Cruz ME; Campos P; Tovar AA; Lucas CM; Berman JD
    Am J Trop Med Hyg; 1994 Jul; 51(1):77-82. PubMed ID: 8059918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies.
    Bryceson AD; Chulay JD; Ho M; Mugambii M; Were JB; Muigai R; Chunge C; Gachihi G; Meme J; Anabwani G
    Trans R Soc Trop Med Hyg; 1985; 79(5):700-4. PubMed ID: 3006294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
    Henao HH; Osorio Y; Saravia NG; Gómez A; Travi B
    Biomedica; 2004 Dec; 24(4):393-402. PubMed ID: 15678803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody.
    Nabors GS; Farrell JP
    Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate.
    Tallab TM; Bahamdam KA; Mirdad S; Johargi H; Mourad MM; Ibrahim K; el Sherbini AH; Karkashan E; Khare AK; Jamal A
    Int J Dermatol; 1996 Aug; 35(8):594-7. PubMed ID: 8854166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.
    Gasser RA; Magill AJ; Oster CN; Franke ED; Grögl M; Berman JD
    Clin Infect Dis; 1994 Jan; 18(1):83-90. PubMed ID: 7519887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.